Financials

Discussions Technicals Seasonals

261780 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

CHA Vaccine Research Institute Co., Ltd. operates as a research-oriented biotechnology company. The firm involves in research and development of vaccine products targeting infectious disease as well as chronic disease. It specializes in proprietary vaccine adjuvant L-pampo and recombinant antigen development platform. The company was founded by Hong Mo Moon on June 13, 2000 and is headquartered in Seongnam-si, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

261780 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company